ReviewFrontiers in immunology2023
SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy.
Pooya Farhangnia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this papercites it